Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01463761
Other study ID # 0908073
Secondary ID 2009-A00674-53
Status Completed
Phase N/A
First received October 31, 2011
Last updated March 5, 2013
Start date July 2010
Est. completion date December 2012

Study information

Verified date March 2013
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)France: French Data Protection Authority
Study type Observational

Clinical Trial Summary

Sports training aims to enhance an athlete's performance (overcompensation). To do that, the athlete must go through periods of fatigue and lower performance (overreaching). When the training plan is balanced, this fatigue is short and reversible.If the training load is too heavy or if recuperation periods are too short, it can lead to persistence fatigue that may only be reversible in the long term. This state of fatigue is part of the broader clinical picture of overtraining, which includes stark changes in performance as well as mood and sleep disorders. Many prediction and characterization methods based on biological markers have been evaluated, but they have not been put into practice in sports training due to obstacles such as reliability, interindividual variability and high costs. This study aims to evaluate a new approach based on the variability of an individual's heart rate (RR variability), which is a way of measuring autonomic nervous system (ASN) activity. It is non-invasive, low-cost, and has already proven useful in athlete health monitoring.


Description:

The investigators propose to describe the variation of these ANS regulation factors over a full year, in a population of high-level athletes, in order to measure changes in regulation which may be predictive of potential fatigue and intolerance to physical training, if such a syndrome came to be observed among the study group.


Recruitment information / eligibility

Status Completed
Enrollment 131
Est. completion date December 2012
Est. primary completion date December 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 14 Years and older
Eligibility Inclusion Criteria:

- High-level athlete, enrolled in a Ministry-recognized Pôle

- Participant signed the informed consent form

Exclusion Criteria:

- Confirmed current overtraining syndrome

- Known pregnancy on inclusion

- Athlete using cardio-inhibitor or cardio-accelerator drugs

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
ANS activity
This ANS activity is measured by nocturnal heart rates records with Holter ECG.

Locations

Country Name City State
France CH Albertville Moutiers Albertville
France CHU de Besançon Besancon
France Université Paris XIII Bobigny
France CHU de Grenoble Grenoble
France CHU de Pointe à Pitre Pointe A Pitre
France CNSN Centre médical de Prémanon Premanon
France CHU de Saint-Etienne Saint-Etienne
France CREPS Toulouse Midi Pyrénées Toulouse

Sponsors (2)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne Minister of Youth Affairs and Sports, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Autonomic nervous system (ANS) activity This ANS is mesured during the night using a spectral analysis of nocturnal heart rate variability. One year No
Primary Fatigue and physical training Fatigue and physical training potetially due to overtraining, suspected based on a very significant, long-term worsening in performance One year No
Secondary kinetic of the ANS activity ANS is mesured during the night using a spectral analysis of nocturnal heart rate variability Every 15 days (from the iclusion to one year) No
Secondary orthostasis test ANS activity measurements (RR variability) during active orthostasis transition on waking up in the morning Every 15 days (from inclusion to one year) No
Secondary French Society of Sports Medicine questionnaire The questionnaire was designed to detect early signs of overtraining. It includes 54 yes/no questions. Subjects who answer "yes" to more than 20 questions are considered at risk for overtraining. Every 15 days (from inclusion to one year) No
Secondary POMS (Profile of Mood States) questionnaire Every 3 months (from inclusion to inclusion) No
Secondary Sleep quality questionnaire The questionnaire is self-administered. It includes two parts. The first part consists of several questions regarding sleep during the previous night. The second part aims to evaluate the physical exertion load during the previous day's training session(s). Participants will fill one questionnaire/day for a whole week. Each questionnaire period must coincide with a training period (interseason, volume, intensity, or competition.) Every 3 months (from inclusion to one year) No
See also
  Status Clinical Trial Phase
Completed NCT04959214 - The Effect Of Progressıve Relaxatıon Exercıses N/A
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Completed NCT04531891 - Utility and Validity of a High-intensity, Intermittent Exercise Protocol N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT04960865 - Kinesio Taping and Calf Muscle Fatigue N/A
Completed NCT02948283 - Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia Phase 1
Completed NCT06421233 - The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels N/A
Active, not recruiting NCT05344183 - Immediate and Short-term Effects of Low-level Laser N/A
Completed NCT04716049 - Effectiveness of Recovery Protocols in Elite Professional Young Soccer Players N/A
Completed NCT00060398 - Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer Phase 3
Recruiting NCT05241405 - Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast Cancer N/A
Active, not recruiting NCT06074627 - Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes N/A
Completed NCT03943212 - The Effect of Blood Flow Rate on Dialysis Recovery Time in Patients Undergoing Maintenance Hemodialysis N/A
Recruiting NCT05567653 - Effects of Probiotics on Gut Microbiota, Endocannabinoid and Immune Activation and Symptoms of Fatigue in Dancers N/A
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT05863897 - e-COGRAT: A Blended eHealth Intervention for Fatigue Following Acquired Brain Injury N/A
Not yet recruiting NCT05002894 - Effect of Pilates Exercises On Fatigue In Post Menopausal Women N/A
Recruiting NCT04091789 - Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea Phase 2
Completed NCT02911649 - Reducing Sedentary Behaviour With Technology N/A
Completed NCT02321358 - Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors N/A